Geron Corp. of Menlo Park, Calif., has launched clinical trials to see whether a telomerase inhibitor can fight lung, breast, pancreatic and other cancers.

• 加州的GeronCorp.；已经开始了有关端粒(酉每)抑制剂是否能抵抗肺癌、乳腺癌、胰腺癌和其他癌症的临床试验。